Clinical Trials
12 trialsNCT07124000 2026-05-01
DP-04
AstraZeneca
Recruiting
NCT02185560 2026-04-14
JPMS-DTC
Bayer
Active not recruiting
NCT05366881 2026-01-20
CAMPERR
Adela, Inc
Recruiting
NCT04028479 2024-12-18
ROOT
Taproot Health
Completed
NCT06583395 2024-11-01
QUANTUM
VitaMed Research LLC
Enrolling by invitation
NCT05994365 2023-08-16
Study of Anlotinib Hydrochloride Capsules in the Treatment of Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Recruiting
NCT02303444 2023-06-08
RIFTOS MKI
Bayer
Completed
NCT05395429 2023-02-23
Clinical Evaluation of Genetron TERT/BRAF PCR Kit in Thyroid Cancer Patients
Genetron Health
Unknown
NCT05025046 2021-09-13
NGS-based Thyroscan Genomic Classifier in the Diagnosis of Thyroid Nodules
Rigen Biotech
Unknown
NCT02430714 2020-01-09
Post-marketing Surveillance of Lenvatinib Mesylate (Lenvima Capsule) in Patients With Unresectable Thyroid Cancer (Study LEN01T)
Eisai Inc.
Completed
NCT02778412 2017-08-21
ctDNA in Patients With Thyroid Nodules
Pathway Genomics
Terminated
NCT01736163 2015-03-23
A Retrospective Observational Study Comparing Two Different Treatment Options in Thyroid Cancer Patients With T4 Tumours
Sanofi
Completed